send to a friend by email
2025-11-04
According to the financial statements for Birzeit Pharmaceuticals BPC of 30/09/2025 Net profit after tax reached 9,813,921 USD, compared with Net profit after tax of 2,255,871 USD at the end of year 2024 a net increase of 335.04%. Total assets reached 132,975,435 USD, compared with Total assets of 128,821,148 USD at the end of year 2024 a net increase of 3.22%. Total Liabilities reached 23,051,646 USD, compared with Total Liabilities of 23,938,158 USD at the end of year 2024 a net decrease of 3.7%. Total Owners' Equity reached 109,923,789 USD Including None-Controlling Interests of 689,572 USD, compared with Total Owners' Equity of 104,882,990 USD Including None-Controlling Interests of 681,286 USD at the end of year 2024 a net increase of 4.81%.
|
|